|
|
|
| |
|
| | DIGAMI 2 trial post hoc analysis: Lessons in overinterpretation | | In their post hoc analysis of the DIGAMI 2 (Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction 2) study, Mellbin and colleagues suggest that insulin therapy after myocardial infarction (MI) may be associated with increased clinical events (not mortality), whereas metformin therapy
may be associated with reduced events and sulfonylurea therapy with neutral effects. | |
| | | | |
|
| |
|
|
|